Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura K Hummers

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 27, 2010
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertensionAránzazu Campo, Stephen C Mathai, Jérôme Le Pavec, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 23, 2024
Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertensionJulie C Coursen, Tijana Tuhy, Mario Naranjo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2025
Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic SclerosisJi Soo Kim, Rachel S Wallwork, Carrie L Richardson, et al.
The Journal of Rheumatology|October 4, 2011
Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertensionStephen C Mathai, Christopher T Sibley, Paul R Forfia, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 31, 2025
Refining Risk Prediction in Systemic Sclerosis-Associated Pulmonary Arterial HypertensionRyan Osgueritchian, Vivek P Jani, Hoda Mombeini, et al.
Journal of Autoimmunity|February 5, 2014
International consensus criteria for the diagnosis of Raynaud's phenomenonEmanual Maverakis, Forum Patel, Daniel G Kronenberg, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Medicine|September 3, 2014
Severity of systemic sclerosis-associated pulmonary arterial hypertension in African AmericansIsabel Blanco, Stephen Mathai, Majid Shafiq, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|March 27, 2010
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertensionAránzazu Campo, Stephen C Mathai, Jérôme Le Pavec, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 23, 2024
Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertensionJulie C Coursen, Tijana Tuhy, Mario Naranjo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2025
Identification of Risk Factors for Incident Left Ventricular Systolic Dysfunction and Predictors of Cardiac Recovery in Patients With Systemic SclerosisJi Soo Kim, Rachel S Wallwork, Carrie L Richardson, et al.
The Journal of Rheumatology|October 4, 2011
Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertensionStephen C Mathai, Christopher T Sibley, Paul R Forfia, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 31, 2025
Refining Risk Prediction in Systemic Sclerosis-Associated Pulmonary Arterial HypertensionRyan Osgueritchian, Vivek P Jani, Hoda Mombeini, et al.
Journal of Autoimmunity|February 5, 2014
International consensus criteria for the diagnosis of Raynaud's phenomenonEmanual Maverakis, Forum Patel, Daniel G Kronenberg, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Medicine|September 3, 2014
Severity of systemic sclerosis-associated pulmonary arterial hypertension in African AmericansIsabel Blanco, Stephen Mathai, Majid Shafiq, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
Pageof 14